Evidence map›Paper›PMID 38648119›Full record

ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2024

Obstructive sleep apnea severity, circulating biomarkers, and cancer risk.

A J Hirsch Allen, Tetyana Kendzerska, Parveen Bhatti, Rachel Jen, Renelle Myers, Mohammadreza Hajipour, Stephan F van Eeden, Najib Ayas

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Does the severity of obstructive sleep apnea increase the risk of cancer? Clues in apnea-hypopnea index and biomarkers.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

A J Hirsch AllenDepartment of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Tetyana KendzerskaDepartment of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Parveen BhattiBC Cancer Research Institute, Vancouver, British Columbia, Canada.
Rachel JenDepartment of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Renelle MyersDepartment of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Mohammadreza HajipourDepartment of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Stephan F van EedenCentre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Najib AyasDepartment of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
University of British Columbia · CASt. Paul's Hospital · CAUniversity of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

objectivesTo determine whether obstructive sleep apnea (OSA) severity and/or biomarkers of inflammation/angiogenesis are associated with incident cancer in this clinical cohort.

methodsConsenting adult patients at the University of British Columbia Hospital between 2003 and 2014 completed a questionnaire about their medical history and sleep habits prior to undergoing a polysomnogram. Blood samples were collected the morning after polysomnography and processed for biomarkers of inflammation and angiogenesis. The clinical, polysomnography, and biomarker data were linked to the British Columbia Cancer Registry to ascertain incident cancer diagnoses. Cox proportional hazard regression was used to assess the association between OSA severity and biomarker concentrations with cancer risk.

resultsA total of 1,990 patients were included in the analysis with a mean follow-up time of 12.8 years; 181 of them (9.1%) developed cancer after polysomnography. OSA severity was significantly associated with cancer risk after controlling for relevant covariates (hazard ratio = 1.08 per 10 events/h apnea-hypopnea index increase, confidence interval = 1.02-1.15,

conclusionsOSA severity was an independent risk factor for cancer. Furthermore, 2 circulating markers were significantly associated with cancer risk. If these preliminary findings can be reproduced in other cohorts, biomarkers could potentially be used to prognosticate patients with OSA with respect to cancer risk. CITATION: Hirsch Allen AJ, Kendzerska T, Bhatti P, et al. Obstructive sleep apnea severity, circulating biomarkers, and cancer risk.

Indexed as

BiomarkersNeoplasmsPolysomnographySeverity of Illness IndexSleep Apnea, ObstructiveAdultBritish ColumbiaCohort StudiesFemaleHumansMaleMiddle AgedRisk FactorsSurveys and QuestionnairesBiomarkersapnea-hypopnea indexcancerobstructive sleep apneapolysomnography

Identifiers

PMID38648119
PMCPMC11367715
OpenAlexW4394993798

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.